Express News | Needham Reiterates Hold on American Well
Benzinga07:44 ET
American Well Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/02/2024 — Needham Reiterates → Hold 04/15/2024 85.19% Morgan Stanley $1.75 → $1 Maintains Equal-Weight
Benzinga07:43 ET
American Well: Hold Rating Amidst Revenue Challenges and Strategic Progress
TipRanks07:06 ET
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), American Well (AMWL) and Glaukos (GKOS)
TipRanks06:13 ET
Compared to Estimates, American Well (AMWL) Q1 Earnings: A Look at Key Metrics
Yahoo Finance19:30 ET
American Well Corporation (AMWL) Reports Q1 Loss, Misses Revenue Estimates
Yahoo Finance18:00 ET
Express News | American Well Sees FY25 Revenue $335M-$350M Vs $322.4M Estimate
Benzinga17:28 ET
Express News | American Well Q1 2024 GAAP EPS $(0.25) Misses $(0.19) Estimate, Sales $59.522M Miss $60.524M Estimate
Benzinga17:07 ET
Express News | American Well Corp - Communicated Its Objective to Attain Adjusted Ebitda Breakeven in 2026
Reuters16:38 ET
Express News | American Well Corp Sees 2025 Revenue in Range of $335 to $350 Million
Reuters16:38 ET
Express News | American Well Corp - Reiterated Its 2024 Guidance
Reuters16:38 ET
Express News | American Well Corp- Qtrly Shr Loss $0.25
Reuters16:38 ET
Express News | American Well Corp- Qtrly Total Revenue of $59.5 Million
Reuters16:37 ET
American Well 1Q Rev $59.5M >AMWL
American Well 1Q Rev $59.5M >AMWL
Dow Jones16:09 ET
Express News | Amwell Announces Results for First Quarter 2024
Reuters16:05 ET
AMWELL ANNOUNCES RESULTS FOR FIRST QUARTER 2024
Boston, May 01, 2024 (GLOBE NEWSWIRE) -- Amwell (NYSE: AMWL) a small-cap, growth healthcare company and a leading provider of healthcare software as a service, today announced financial results for
GlobeNewswire16:05 ET
Express News | NYSE Order Imbalance 73836.0 Shares on Buy Side
Reuters15:50 ET
Amwell Releases 2024 Corporate Responsibility Report
Report demonstrates company progress toward enabling digital healthcare with purposeBoston, April 29, 2024 (GLOBE NEWSWIRE) -- Amwell (NYSE: AMWL), a leader in hybrid care enablement, today announce
GlobeNewswireApr 29 07:00 ET
Express News | NYSE Order Imbalance 70766.0 Shares on Buy Side
ReutersApr 26 15:50 ET
Amwell to Participate in Upcoming Investor Conference
Boston, April 25, 2024 (GLOBE NEWSWIRE) -- Amwell (NYSE: AMWL), a leader in hybrid care enablement, announced that the company will participate in the Needham Technology, Media and Consumer Conferen
GlobeNewswireApr 25 07:00 ET
No Data
No Data